Based on the Avanos Medical Inc stock forecast from 0 analysts, the average analyst target price for Avanos Medical Inc is not available over the next 12 months. Avanos Medical Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Avanos Medical Inc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Avanos Medical Inc’s stock price was USD 16.02. Avanos Medical Inc’s stock price has changed by -0.99% over the past week, -17.29% over the past month and -29.74% over the last year.
No recent analyst target price found for Avanos Medical Inc
No recent average analyst rating found for Avanos Medical Inc
Company Overview Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Read Less
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enter...Read More
Frequently Asked Questions About Avanos Medical Inc (AVNS) Stock
Stock Target Advisor's fundamental analysis for Avanos Medical Inc's stock is Neutral.
Unfortunately we do not have enough data on AVNS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AVNS's stock to indicate what its average analyst target is.
AVNS stock's Price/Earning ratio is 34.21.
Our analysis grades AVNS stock's Price / Earning ratio at C. This means that AVNS stock's Price/Earning ratio is above 25% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this AVNS may be undervalued for its sector.
The last closing price of AVNS's stock was USD 16.02.
The most recent market capitalization for AVNS is USD 0.74B.
Unfortunately we do not have enough analyst data on AVNS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Avanos Medical Inc's stock.
As per our most recent records Avanos Medical Inc has 3,771 Employees.
Avanos Medical Inc's registered address is 5405 Windward Parkway, Alpharetta, GA, United States, 30004.
You can get more information about it from Avanos Medical Inc's website at https://avanos.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Avanos Medical Inc (AVNS) Stock
Stock Target Advisor's fundamental analysis for Avanos Medical Inc's stock is Neutral.
Unfortunately we do not have enough data on AVNS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AVNS's stock to indicate what its average analyst target is.
AVNS stock's Price/Earning ratio is 34.21.
Our analysis grades AVNS stock's Price / Earning ratio at C. This means that AVNS stock's Price/Earning ratio is above 25% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this AVNS may be undervalued for its sector.
The last closing price of AVNS's stock was USD 16.02.
The most recent market capitalization for AVNS is USD 0.74B.
Unfortunately we do not have enough analyst data on AVNS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Avanos Medical Inc's stock.
As per our most recent records Avanos Medical Inc has 3,771 Employees.
Avanos Medical Inc's registered address is 5405 Windward Parkway, Alpharetta, GA, United States, 30004.
You can get more information about it from Avanos Medical Inc's website at https://avanos.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AVNS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
